CPS-166 - The risks and benefits associated with the self-selection of medications: A systematic review

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: CPS-166
• By: ASHIRU-OREDOPE, Diane
• Co-author(s): Lauren Ross (Royal Pharmaceutical Society, London, United Kingdom)
  Leah Burton (Royal Pharmaceutical Society, London, United Kingdom)
  James Davies (Royal Pharmaceutical Society, London, United Kingdom)
  Laura Wilson (Royal Pharmaceutical Society, London, United Kingdom)
  Elen Jones (Royal Pharmaceutical Society, London, United Kingdom)
  Wing Tang (Royal Pharmaceutical Society, London, United Kingdom)
  Amira Guirguis (Faculty of Medicine, Health and Life Science, Swansea University, Swansea , United Kingdom )
  Parastou Donyai (Royal Pharmaceutical Society, London, United Kingdom)
  Prof Diane Ashiru-Oredope (Royal Pharmaceutical Society, London, United Kingdom)
  
• Abstract:

  Introduction
  The three classes of medicinal products for humans under the Human Medicines Regulations 2012 in the UK are General Sales List (GSL) Medicines, Pharmacy Medicines (PMEDs), and Prescription-only Medicines (POMs). PMEDs, for short-term treatment of transient medical conditions have traditionally been stored in pharmacies to limit..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login